Treace Medical Concepts, Inc. (TMCI)
4.63
-0.18
(-3.74%)
USD |
NASDAQ |
Sep 08, 16:00
4.645
+0.02
(+0.32%)
After-Hours: 20:00
Treace Medical Concepts Net Income (Quarterly) : -15.87M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -15.87M |
| March 31, 2026 | -17.96M |
| December 31, 2025 | -9.394M |
| September 30, 2025 | -16.29M |
| June 30, 2025 | -17.40M |
| March 31, 2025 | -15.92M |
| December 31, 2024 | -0.501M |
| September 30, 2024 | -15.36M |
| June 30, 2024 | -21.21M |
| March 31, 2024 | -18.68M |
| December 31, 2023 | -6.281M |
| September 30, 2023 | -17.52M |
| June 30, 2023 | -12.27M |
| March 31, 2023 | -13.45M |
| December 31, 2022 | -4.412M |
| Date | Value |
|---|---|
| September 30, 2022 | -12.13M |
| June 30, 2022 | -17.23M |
| March 31, 2022 | -9.036M |
| December 31, 2021 | -6.619M |
| September 30, 2021 | -6.418M |
| June 30, 2021 | -5.083M |
| March 31, 2021 | -2.432M |
| December 31, 2020 | 2.565M |
| September 30, 2020 | -2.655M |
| June 30, 2020 | -1.973M |
| March 31, 2020 | -1.607M |
| December 31, 2019 | 1.885M |
| September 30, 2019 | -2.695M |
| June 30, 2019 | -1.561M |
| March 31, 2019 | -1.894M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Tactile Systems Technology, Inc. | 7.785M |
| Abbott Laboratories | 928.00M |
| AngioDynamics, Inc. | -11.40M |
| Alphatec Holdings, Inc. | -25.78M |
| AtriCure, Inc. | 8.955M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 45.38M |
| Total Expenses (Quarterly) | 61.25M |
| EPS Diluted (Quarterly) | -0.244 |
| Enterprise Value | 329.48M |
| Gross Profit Margin (Quarterly) | 78.47% |
| Profit Margin (Quarterly) | -34.98% |
| Earnings Yield | -19.99% |
| Normalized Earnings Yield | -19.34 |